PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Blackstone appoints MD to lead European investing for Blackstone Growth

Blackstone has appointed Paul Morrissey, a seasoned investment professional with extensive private equity and venture capital experience, as a Managing Director to lead investing across Europe for Blackstone Growth (BXG).

This newly created role will see Morrissey manage the European deployment for BXG, which recently completed the final close of its oversubscribed, inaugural USD4.5 billion growth equity fund – the largest first-time growth equity private vehicle ever raised. BXG has already made significant investments in fast-growing European companies, including Epidemic Sound, which delivers restriction-free music to internet content creators across the globe, and oat milk pioneer, Oatly.

Jon Korngold, Global Head of Blackstone Growth, says: “I’m delighted that Paul has joined us to lead BXG in Europe. Paul is a world-class growth equity investor and his appointment underlines Blackstone’s already-strong commitment to partnering with fast-growing European companies to help them become global industry leaders by providing them with access to a scale of resources not typically available to this market.”

Morrissey says: “I’m excited to join Blackstone and look forward to working with the team to extend BXG’s leadership position as a highly strategic partner to growth-stage companies. Blackstone’s immense scale and operational expertise affords entrepreneurs the ability to pursue transformational growth opportunities that might not have been available to them in the past.”

Morrissey most recently served as a partner at the technology-focused investing firm, Battery Ventures, where he established Battery’s London office and led many successful investments in global growth businesses. Prior to Battery, Morrissey spent time at Goldman Sachs, where he focused on advising companies in the technology industry. He graduated from Stanford University with a BA in Economics and was featured in Forbes “30 under 30” earlier in his career.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured